![Marcel Gremaud](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/03/2026
Marcel Gremaud is the founder of Gremaud GmbH, holding the title of Chief Executive Officer since 2001.
Mr. Gremaud is the founder of Altamira Therapeutics Ltd., holding the title of Chief Financial Officer since 2021.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/04/2025 | 0 ( -.--% ) | - $ | 31/03/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Director Financiero/CFO | 01/11/2021 |
Gremaud GmbH | Director Ejecutivo | 01/01/2001 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 2 |
|---|---|
Altamira Therapeutics Ltd.
 Altamira Therapeutics Ltd. BiotechnologyHealth Technology Develops RNA therapeutics for inner ear disorders | Health Technology |
Gremaud GmbH |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
